Pharmacological fibrinolysis in diabetes mellitus.

作者信息

Chakrabarti R, Fearnley G R

出版信息

Diabetologia. 1974 Feb;10(1):19-22. doi: 10.1007/BF00421409.

DOI:10.1007/BF00421409

PMID:4835611

Abstract

摘要

相似文献

Pharmacological fibrinolysis in diabetes mellitus.

Diabetologia. 1974 Feb;10(1):19-22. doi: 10.1007/BF00421409.

Effects on platelet stickiness and fibrinolysis of phenformin combined with ethyloestrenol or stanozolol.

Lancet. 1970 Mar 21;1(7647):591-3. doi: 10.1016/s0140-6736(70)91628-4.

Fibrinolytic and defibrinating effect of phenformin plus ethyloestrenol in vivo.

Lancet. 1969 May 3;1(7601):910-4. doi: 10.1016/s0140-6736(69)92545-8.

Comparative effects of platelet adhesiveness by phenformin combined with ethylestrenol or stanozolol.

Acta Univ Carol Med Monogr. 1972;53:261-2.

Synthetic activators of fibrinolysis.

Acta Clin Belg. 1977;32(6):428-33. doi: 10.1080/17843286.1977.11717898.

Effect of ethyloestrenol combined with phenformin or with metformin on platelet stickiness and serum-cholesterol in patients with occlusive vascular disease.

Lancet. 1968 Nov 9;2(7576):1004-7. doi: 10.1016/s0140-6736(68)91297-x.

Fibrinolytic activity and postoperative deep-vein thrombosis.

Lancet. 1974 Jan 5;1(7845):9-11. doi: 10.1016/s0140-6736(74)93000-1.

The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).

Acta Univ Carol Med Monogr. 1972;52:19-23.

Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.

Scand J Haematol. 1970;7(5):404-8. doi: 10.1111/j.1600-0609.1970.tb01922.x.

Pharmacological stimulation of fibrinolytic activity in the surgical patient.

Lancet. 1971 Apr 17;1(7703):774-6. doi: 10.1016/s0140-6736(71)91215-3.

引用本文的文献

Glucose intolerance, diabetes mellitus and atherosclerosis; prospects for prevention.

Postgrad Med J. 1976 Jul;52(609):445-51. doi: 10.1136/pgmj.52.609.445.

本文引用的文献

A postmortem study of vascular disease in diabetics.

AMA Arch Pathol. 1952 May;53(5):444-55.

CORONARY HEART DISEASE IN THE DIABETIC PATIENT.

Med Clin North Am. 1965 Jul;49:1093-104. doi: 10.1016/s0025-7125(16)33298-9.

FIBRINOLYSIS IN OBESITY.

Lancet. 1964 Dec 5;2(7371):1205-7. doi: 10.1016/s0140-6736(64)91042-6.

PHARMACOLOGICAL ENCHANCEMENT OF FIBRINOLYTIC ACTIVITY OF BLOOD.

J Clin Pathol. 1964 May;17(3):328-32. doi: 10.1136/jcp.17.3.328.

Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity.

Br Med J. 1963 Apr 6;1(5335):921-3. doi: 10.1136/bmj.1.5335.921.

Reduction of blood fibrinolytic activity in diabetes mellitus by insulin.

Lancet. 1959 Dec 12;2(7111):1067. doi: 10.1016/s0140-6736(59)91534-x.

Effect of the sulphonylureas on fibrinolysis.

Lancet. 1960 Sep 17;2(7151):622-5. doi: 10.1016/s0140-6736(60)91694-9.

Metabolism of the serum lipids in diabetes and in arteriosclerosis.

Diabetes. 1955 Jul-Aug;4(4):273-9. doi: 10.2337/diab.4.4.273.

Evidence of an active fibrinolytic enzyme in the plasma of normal people with observations on inhibition associated with the presence of calcium.

Clin Sci. 1953 Feb;12(1):81-9.

Platelet adhesiveness, plasma fibrinogen and factor 8 levels in diabetes mellitus.

Diabetologia. 1970 Aug;6(4):436-40. doi: 10.1007/BF01212078.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验